Hidden cancer risks for Hysterectomy and Fibroid Removal
Posted in Drug & Medical Devices on July 10, 2015
Uterine cancer is the fourth most common cancer in women in the United States and the most commonly diagnosed gynecologic cancer. Prior to a hysterectomy or fibroid removal (myomectomy), the FDA estimates that approximately 1 in 350 women have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma. Stages of Endometrial...
J&J Pulls Hysterectomy Tool Due to Cancer Risk
Posted in Drug & Medical Devices on August 1, 2014
Johnson & Johnson has asked all hospitals to return a surgical device that can spread cancer in women being treated for uterine growths called fibroids. The company has instituted a voluntary “worldwide market withdrawal” of the surgical tool known as a laparoscopic power morcellator. During laparoscopic hysterectomies and myomectomies, surgeons use a power morcellator...